Adjuvant Chemotherapy Effects on Renal-Impaired Patients After Nephroureterectomy for UTUC

This multicenter retrospective study evaluates the impact of adjuvant platinum-based chemotherapy on oncological outcomes in high-risk upper tract urothelial carcinoma patients with postoperative renal impairment following radical nephroureterectomy. The study compares disease-free and overall survival between patients receiving chemotherapy and those who did not, as well as between different chemotherapy regimens. The findings aim to clarify treatment benefits for this specific patient group.

Originally published by gnews